Chiesa's Injury and Leao's Biography: Serie A News Roundup

2 min read | February 29, 2024 11:33 AM GMT | By Team Kalkine Media

In the latest Serie A news, Juventus winger Federico Chiesa suffered a knock during a training session on Wednesday but is expected to be fit for the upcoming clash against Napoli. Chiesa, who was accidentally hit by teammate Alex Sandro, ended the session prematurely. However, Juventus medical staff are optimistic about his recovery and will assess him again on Thursday. Meanwhile, before the training session, midfielder Adrien Rabiot marked his 200th appearance for the club. 
 
Read More: LSE: SUP Soars in H1 FY24 with 62.7% Revenue Growth, 182% EPS Increase 

On the stadium front, both Milan and Inter have been notified about plans to redevelop the Stadio Meazza. However, reports suggest that neither club is keen on remaining at San Siro. Inter, currently facing Atalanta in the rescheduled fixture from Week 21, seem to be focused on their match despite the stadium discussions. Meanwhile, earlier in the day, Napoli secured a convincing 6-1 victory over Sassuolo at the Mapei Stadium in Reggio Emilia. 

In other news, AC Milan's Rafael Leao made headlines as he launched his book titled 'Smile' during a special event in Milan. The star forward's biography promises insights into his life and career, adding another dimension to his already burgeoning reputation in Italian football. 

Meanwhile, at AS Roma, new manager Daniele De Rossi has made an impressive start at the Stadio Olimpico, earning 15 points from 18 available in the league. This marks a significant improvement over his predecessor, José Mourinho, who managed only eight points against the same opponents earlier in the season. Additionally, Roma announced a new partnership with JD Sports, further bolstering their off-field endeavors. 

As the Serie A season progresses, these developments add layers of intrigue to the Italian football landscape, highlighting the ongoing drama both on and off the pitch. 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next